TY  - JOUR 
AU  - Iglesias, P.
AU  - Seoane, M.
AU  - Golán-Cancela, I.
AU  - Fraga, M.
AU  - Arce, V.M.
AU  - Costoya Puente, José Antonio
PY  - 2023
SN  - 1422-0067
UR  - http://hdl.handle.net/20.500.11940/20990
AB  - In recent years, new therapies have been developed based on molecules that target molecular mechanisms involved in both the initiation and maintenance of the oncogenic process. Among these molecules are the poly(ADP-ribose) polymerase 1 (PARP1)...
LA  - eng
KW  - Humans
KW  - Poly(ADP-ribose) Polymerases
KW  - Poly(ADP-ribose) Polymerase Inhibitors
KW  - Poly (ADP-Ribose) Polymerase-1
KW  - Neoplasms
KW  - DNA Repair
KW  - Transcription Factors
TI  - A New Opportunity for "Old" Molecules: Targeting PARP1 Activity through a Non-Enzymatic Mechanism
DO  - 10.3390/ijms24108849
T2  - International Journal of Molecular Sciences
KW  - IDIS
VL  - 24
ER  -